Table 1 Pearson correlation analysis was used to analyze the correlation between IL1RL1 gene expression level and clinicopathological features. *P < 0.05, **P < 0.01, ***P < 0.001.
Variables | Number of cases | IL1RL1 mRNA expression | X² | P | ||
---|---|---|---|---|---|---|
low | high | |||||
Sex | Male | 247 | 127 | 120 | 0.046 | 0.831 |
Female | 137 | 72 | 65 | |||
Diagnosis Age | ≥ 65 | 220 | 117 | 103 | 0.381 | 0.537 |
<65 | 164 | 82 | 82 | |||
Local Invasion | T2 | 79 | 45 | 34 | 5.933 | 0.115 |
T3 | 174 | 92 | 82 | |||
T4 | 112 | 49 | 63 | |||
T1 | 19 | 13 | 6 | |||
Lymph Node Stage | N0 | 121 | 80 | 41 | 14.98 | 0.005*** |
N2 | 77 | 34 | 43 | |||
N3 | 80 | 37 | 43 | |||
NX | 5 | 3 | 2 | |||
N1 | 101 | 45 | 56 | |||
Cancer Metastasis Stage Code | MX | 17 | 4 | 13 | 9.547 | 0.008*** |
M0 | 341 | 186 | 155 | |||
M1 | 26 | 9 | 17 | |||
TNM stage | Stage I | 55 | 35 | 20 | 11.888 | 0.008*** |
Stage III | 167 | 78 | 89 | |||
Stage II | 122 | 72 | 50 | |||
Stage IV | 40 | 14 | 26 |